Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Erschienen in: memo - Magazine of European Medical Oncology 4/2020

01.12.2020 | editorial

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer with peritoneal metastasis: Status quo and how should we proceed

verfasst von: Prim. Prof. Dr. Ingmar Königsrainer

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten
share
TEILEN

Excerpt

Metastatic disease in colorectal cancer (CRC) is a challenging multidisciplinary disease, nowadays, embracing all oncological disciplines. …
Literatur
2.
Zurück zum Zitat Maggiori L, Goéré D, Viana B, Tzanis D, Dumont F, Honoré Ch, et al. Should patients with peritoneal carcinomatosis of colorectal origin with synchronous liver metastases be treated with a curative intent? A case-control study. Ann Surg. 2013;258(1):116–21. CrossRef Maggiori L, Goéré D, Viana B, Tzanis D, Dumont F, Honoré Ch, et al. Should patients with peritoneal carcinomatosis of colorectal origin with synchronous liver metastases be treated with a curative intent? A case-control study. Ann Surg. 2013;258(1):116–21. CrossRef
Metadaten
Titel
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer with peritoneal metastasis: Status quo and how should we proceed
verfasst von
Prim. Prof. Dr. Ingmar Königsrainer
Publikationsdatum
01.12.2020
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 4/2020
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-020-00655-4